Arg25Pro polymorphism of transforming growth factor-β1 and its role in the pathogenesis of essential hypertension in Russian population of the Central Chernozem Region

Bulletin of Experimental Biology and Medicine

Volumn 144, Issue 1, 2007, Pages 66-68

  Ivanov, V P ^a   Solodilova, M A ^a   Polonnikov, A V ^a   Belugin, D A ^a   Shestakov, A M ^a   Ushachev, D V ^a   Khoroshaya, I V ^a   Katargina, L N ^a   Kozhukhov, M A ^a   Kolesnikova, O E ^a  

^a KURSK STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Analysis of association; DNA polymorphism; Essential hypertension; Transforming growth factor 1

Indexed keywords

ARGININE; GENOMIC DNA; PROLINE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; RUSSIAN FEDERATION; SEX DIFFERENCE; VOLUNTEER;

FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTENSION; MALE; POLYMORPHISM, GENETIC; RUSSIA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 36349000570     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-007-0256-y     Document Type: Article

References (8)

1. M. R. Awad, A. El-Gamel, P. Hasleton et al. Transplantation, 66, No. 8, 1014-1020 (1998).
2. G. C. Blobe, W. P. Schiemann, and H. F. Lodish, N. Engl. J. Med., 342, No. 18, 1350-1358 (2000).
3. F. Cambien, S. Ricard, A. Troesch, et al., Hypertension, 28, No. 5, 881-887 (1996).
4. B. Li, A. Khanna, V. Sharma, et al., Ibid., 33, No. 1, Pt. 2, 271-275 (1999).
5. P. J. Lijnen, V. V. Petrov, and R. H. Fagard, Am. J. Hypertens., 16, No. 7, 604-611 (2003).
6. A. M. Roberts and M. B. Sporn, Adv. Cancer Res., 51, 107-145 (1988).
7. P. Syrris, N. D. Carter, J. C. Metcalfe, et al., Clin. Sci. (Lond.), 95, No. 6, 659-667 (1998).
8. Y. Yamada, M. Fujisawa, F. Ando, et al., J. Hum. Genet., 47, No. 5, 243-248 (2002).